Citation Impact
Citing Papers
Risks of gastrointestinal bleeding during secondary prevention of vascular events with aspirin--analysis of gastrointestinal bleeding during the UK-TIA trial.
1995
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies
2010 Standout
The Increasing Secondary Care Burden of Idiopathic Pulmonary Fibrosis
2013
In situ click chemistry generation of cyclooxygenase-2 inhibitors
2017 Standout
Increasing Global Mortality from Idiopathic Pulmonary Fibrosis in the Twenty-First Century
2014
Occupational dust exposure and the aetiology of cryptogenic fibrosing alveolitis
2001
Hypertension, serum insulin, obesity and the metabolic syndrome
1998
Non-steroidal anti-inflammatory drugs for low back pain
2008
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
2009 Standout
Nonsteroidal Anti-Inflammatory Drugs for Low Back Pain
2008
Lansoprazole for the Prevention of Recurrences of Ulcer Complications from Long-Term Low-Dose Aspirin Use
2002 Standout
Idiopathic pulmonary fibrosis
2017 Standout
Efficacy of Esomeprazole (20 mg Once Daily) for Reducing the Risk of Gastroduodenal Ulcers Associated With Continuous Use of Low-Dose Aspirin
2008
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
2009 Standout
Inflammation and cancer
2002 StandoutNature
Risk of Hospitalization for Upper Gastrointestinal Tract Bleeding Associated With Ketorolac, Other Nonsteroidal Anti-inflammatory Drugs, Calcium Antagonists, and Other Antihypertensive Drugs
1998
Clopidogrel with or without Omeprazole in Coronary Artery Disease
2010 Standout
Case-Control Study of Idiopathic Pulmonary Fibrosis and Environmental Exposures
1998
Telomerase Mutations in Families with Idiopathic Pulmonary Fibrosis
2007 StandoutNobel
Future trends in the development of safer nonsteroidal anti-inflammatory drugs
1998
Consensus statement on best practice management regarding the use of intravesical immunotherapy with BCG for bladder cancer
2015
Mechanism of Action of Anti-Inflammatory Drugs
1996
A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
2014 Standout
Rivaroxaban in Patients with a Recent Acute Coronary Syndrome
2011 Standout
A randomized trial comparing the effect of rofecoxib, a cyclooxygenase 2–specific inhibitor, with that of ibuprofen on the gastroduodenal mucosa of patients with osteoarthritis
1999
Impaired mucosal defense to acute colonic injury in mice lacking cyclooxygenase-1 or cyclooxygenase-2
2000 StandoutNobel
Comparison of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients with Rheumatoid Arthritis
2000 Standout
New Antithrombotic Drugs
2012
Nitrovasodilators, Low-Dose Aspirin, Other Nonsteroidal Antiinflammatory Drugs, and the Risk of Upper Gastrointestinal Bleeding
2000
Platelet-Active Drugs
1998
Non-specific low back pain
2016 Standout
Mortality from Pulmonary Fibrosis Increased in the United States from 1992 to 2003
2007
Cyclo‐oxygenase‐2: pharmacology, physiology, biochemistry and relevance to NSAID therapy
1999
Targeted disruption of the neuronal nitric oxide synthase gene
1993 Standout
Cardiovascular Risk Associated with Celecoxib in a Clinical Trial for Colorectal Adenoma Prevention
2005 Standout
Anti-inflammatory and Upper Gastrointestinal Effects of Celecoxib in Rheumatoid Arthritis
1999
Obesity
2005 Standout
Interstitial lung disease clinics for the management of idiopathic pulmonary fibrosis: a potential advantage to patients
1999
Omeprazole Compared with Misoprostol for Ulcers Associated with Nonsteroidal Antiinflammatory Drugs
1998
Occupational and Environmental Risk Factors for Idiopathic Pulmonary Fibrosis: A Multicenter Case-Control Study
2000
Platelet Activation and Atherothrombosis
2007 Standout
Clopidogrel with Aspirin in Acute Minor Stroke or Transient Ischemic Attack
2013 Standout
Antiplatelet Drugs
2012
Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial
2004 Standout
Gastrointestinal Toxicity With Celecoxib vs Nonsteroidal Anti-inflammatory Drugs for Osteoarthritis and Rheumatoid Arthritis
2000 Standout
Stroke
2008 Standout
Ankylosing spondylitis
2007 Standout
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
2009 Standout
Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK
2006
Bladder cancer
2016 Standout
Relative Risk of Upper Gastrointestinal Complications among Users of Acetaminophen and Nonsteroidal Anti-Inflammatory Drugs
2001
Circulating concentrations of insulin markers and coronary heart disease: a quantitative review of 19 Western prospective studies
2007
The relation between Helicobacter pylori and nonsteroidal anti-inflammatory drugs
1998
Is Idiopathic Pulmonary Fibrosis an Environmental Disease?
2006
Comparative Safety and Tolerability of Clopidogrel and Aspirin
1999
Gastrointestinal Toxicity of Nonsteroidal Antiinflammatory Drugs
1999 Standout
Idiopathic Pulmonary Fibrosis
2001 Standout
Rheumatoid arthritis
2010 Standout
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
2010 Standout
Medication toxicity among patients with ankylosing spondylitis
2002
Aspirin Dose for the Prevention of Cardiovascular Disease
2007
Alzheimer's Disease
2004 Standout
Idiopathic pulmonary fibrosis
2011 Standout
Cyclooxygenase Inhibitors and the Antiplatelet Effects of Aspirin
2001 Standout
Adult familial cryptogenic fibrosing alveolitis in the United Kingdom
2000
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
2009 Standout
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
2009 Standout
Gastrointestinal tolerability of meloxicam and piroxicam: a double‐blind placebo‐controlled study
1998
Randomised controlled trial of Helicobacter pylori eradication in patients on non-steroidal anti-inflammatory drugs: HELP NSAIDs study
1998
COX-2 inhibitors
1999 Standout
Platelet-Active Drugs
2001
Platelet-Active Drugs: The Relationships Among Dose, Effectiveness, and Side Effects
2004
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes
2007 Standout
Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial
2006 Standout
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
2009 Standout
Prediction of Coronary Heart Disease Using Risk Factor Categories
1998 Standout
Association between aspirin and upper gastrointestinal complications: Systematic review of epidemiologic studies
2001
A double-blind, placebo-controlled trial of diclofenac/misoprostol in Alzheimer’s disease
1999
Gastroduodenal Tolerance of 75 mg Clopidogrel versus 325 mg Aspirin in Healthy Volunteers: A Gastroscopic Study
2000
CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016
2016 Standout
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Role of Prostacyclin in the Cardiovascular Response to Thromboxane A 2
2002 StandoutScience
Reduced Risk of Colorectal Cancer among Long-Term Users of Aspirin and Nonaspirin Nonsteroidal Antiinflammatory Drugs
2001
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism
2012 Standout
Distribution and Correlates of Insulin in Elderly Men
1995
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
The Mammalian Circadian Timing System: Organization and Coordination of Central and Peripheral Clocks
2010 Standout
Hyperinsulinemia Predicts Coronary Heart Disease Risk in Healthy Middle-aged Men
1998
Risk of serious NSAID‐related gastrointestinal events during long‐term exposure: a systematic review
2006
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
2009 Standout
Aspirin as an Adjunct to Screening for Prevention of Sporadic Colorectal Cancer: A Cost-Effectiveness Analysis
2001
Idiopathic Pulmonary Fibrosis
2018 Standout
Infantile hypertrophic pyloric stenosis: A review
1982
The Use of Aspirin for Primary Prevention of Colorectal Cancer: A Systematic Review Prepared for the U.S. Preventive Services Task Force
2007
Works of Robert A. Logan being referenced
Glucose tolerance, plasma insulin, HDL cholesterol and obesity: 12-year follow-up and development of coronary heart disease in Edinburgh men
1992
Effects of ethanol intake and ethanol withdrawal on free-running circadian activity rhythms in rats
2005
Prophylactic aspirin and risk of peptic ulcer bleeding
1995
Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis
1996
Serum cholecystokinin, basal acid secretion, and infantile pyloric stenosis.
1979
Rising mortality from cryptogenic fibrosing alveolitis.
1990